Angina therapies
Executive Summary
FDA's Cardio-Renal Drugs Advisory Committee will address all organic nitrates for long-term treatment of angina at its next meeting, scheduled for Jan. 26-27 at Jack Masur Auditorium on the NIH campus. The meeting is likely to include a discussion of efficacy data for transdermal nitroglycerin patches. Three patch marketers, Schering (Key's Nitro-Dur), Ciba-Geigy (Transderm-Nitro) and Searle (Nitro-disc), jointly sponsored a study to look at the efficacy of nitroglycerin patches....